James S. Blachly
- Hematology top 1%
- Acute Myeloid Leukemia Research 57
- Chronic Myeloid Leukemia Treatments 15
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 48
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 10
-
- Lymphoma Diagnosis and Treatment 16
- Immunology top 10%
-
- Acute Lymphoblastic Leukemia research 18
-
- Histone Deacetylase Inhibitors Research 13
- Protein Degradation and Inhibitors 11
- Co-authors
- John C. ByrdRobert A. BaiocchiMichael R. GreverShelley OrwickClara D. BloomfieldJessica KohlschmidtDeedra NicoletKrzysztof Mrózek
- Cited by
- HematologyGeneticsCancer Research
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
James S. Blachly
112 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 85
- Hematology 778
- Genetics 560
- Cancer Research 277
- Pathology and Forensic Medicine 305
- Immunology 256
Countries citing papers authored by James S. Blachly
This map shows the geographic impact of James S. Blachly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James S. Blachly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James S. Blachly more than expected).
Fields of papers citing papers by James S. Blachly
This network shows the impact of papers produced by James S. Blachly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James S. Blachly. The network helps show where James S. Blachly may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James S. Blachly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 15 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 7 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 7 | |
| 8 | 2020 | 27 | |
| 9 | 2020 | 57 | |
| 10 | 2020 | 21 | |
| 11 | 2020 | 37 | |
| 12 | 2020 | 6 | |
| 13 | 2019 | 29 | |
| 14 | 2019 | 26 | |
| 15 | 2017 | 23 | |
| 16 | 2017 | 0 | |
| 17 | 2016 | 16 | |
| 18 | 2016 | 13 | |
| 19 | 2016 | 53 | |
| 20 | 2016 | 13 |
About James S. Blachly
James S. Blachly is a scholar working on Hematology, Genetics and Cancer Research, having authored 126 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (57 papers), Chronic Lymphocytic Leukemia Research (48 papers), Acute Lymphoblastic Leukemia research (18 papers), Lymphoma Diagnosis and Treatment (16 papers), Chronic Myeloid Leukemia Treatments (15 papers), Histone Deacetylase Inhibitors Research (13 papers), Protein Degradation and Inhibitors (11 papers) and Cancer Genomics and Diagnostics (10 papers). The work is most often cited by research in Hematology (778 citations), Genetics (560 citations) and Cancer Research (277 citations). James S. Blachly has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include John C. Byrd, Robert A. Baiocchi, Michael R. Grever, Shelley Orwick, Clara D. Bloomfield, Jessica Kohlschmidt, Deedra Nicolet, Krzysztof Mrózek, Jonathan E. Kolitz and Richard M. Stone.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.